BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 31088250)

  • 21. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
    Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
    PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of mTORC1 in B Lymphocytes Promotes Osteoclast Formation via Regulation of β-Catenin and RANKL/OPG.
    Xu S; Zhang Y; Liu B; Li K; Huang B; Yan B; Zhang Z; Liang K; Jia C; Lin J; Zeng C; Cai D; Jin D; Jiang Y; Bai X
    J Bone Miner Res; 2016 Jul; 31(7):1320-33. PubMed ID: 26825871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
    Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
    Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive-Feedback Regulation of Subchondral H-Type Vessel Formation by Chondrocyte Promotes Osteoarthritis Development in Mice.
    Lu J; Zhang H; Cai D; Zeng C; Lai P; Shao Y; Fang H; Li D; Ouyang J; Zhao C; Xie D; Huang B; Yang J; Jiang Y; Bai X
    J Bone Miner Res; 2018 May; 33(5):909-920. PubMed ID: 29329496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteocyte-intrinsic mTORC1 signaling restrains trabecular bone accrual in mice.
    Liu Q; Liu C; Yang Y; Yang H; Chen J
    J Cell Biochem; 2018 Nov; 119(11):8743-8749. PubMed ID: 30160781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberous sclerosis complex-mediated mTORC1 overactivation promotes age-related hearing loss.
    Fu X; Sun X; Zhang L; Jin Y; Chai R; Yang L; Zhang A; Liu X; Bai X; Li J; Wang H; Gao J
    J Clin Invest; 2018 Nov; 128(11):4938-4955. PubMed ID: 30247156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption.
    Kitaura H; Marahleh A; Ohori F; Noguchi T; Shen WR; Qi J; Nara Y; Pramusita A; Kinjo R; Mizoguchi I
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro.
    Wu Q; Zhou X; Huang D; Ji Y; Kang F
    Cell Physiol Biochem; 2017; 41(4):1360-1369. PubMed ID: 28278513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of SOST gene promotes bone formation through the Wnt/β-catenin signalling pathway and compensates particle-induced osteolysis.
    Zhang ZH; Jia XY; Fang JY; Chai H; Huang Q; She C; Jia P; Geng C; Xu W
    J Cell Mol Med; 2020 Apr; 24(7):4233-4244. PubMed ID: 32134561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberous sclerosis complex is required for tumor maintenance in MYC-driven Burkitt's lymphoma.
    Hartleben G; Müller C; Krämer A; Schimmel H; Zidek LM; Dornblut C; Winkler R; Eichwald S; Kortman G; Kosan C; Kluiver J; Petersen I; van den Berg A; Wang ZQ; Calkhoven CF
    EMBO J; 2018 Nov; 37(21):. PubMed ID: 30237309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mTORC1 activation is not sufficient to suppress hepatic PPARα signaling or ketogenesis.
    Selen ES; Wolfgang MJ
    J Biol Chem; 2021 Jul; 297(1):100884. PubMed ID: 34146544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced glycation end-product 2 and Porphyromonas gingivalis lipopolysaccharide increase sclerostin expression in mouse osteocyte-like cells.
    Sakamoto E; Kido JI; Takagi R; Inagaki Y; Naruishi K; Nagata T; Yumoto H
    Bone; 2019 May; 122():22-30. PubMed ID: 30735798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of AMP-activated protein kinase decreases receptor activator of NF-κB ligand expression and increases sclerostin expression by inhibiting the mevalonate pathway in osteocytic MLO-Y4 cells.
    Yokomoto-Umakoshi M; Kanazawa I; Takeno A; Tanaka K; Notsu M; Sugimoto T
    Biochem Biophys Res Commun; 2016 Jan; 469(4):791-6. PubMed ID: 26713363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of histone deacetylase inhibitor Scriptaid and parathyroid hormone on osteocyte functions and metabolism.
    Sun N; Uda Y; Azab E; Kochen A; Santos RNCE; Shi C; Kobayashi T; Wein MN; Divieti Pajevic P
    J Biol Chem; 2019 Jun; 294(25):9722-9733. PubMed ID: 31068415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading.
    Tu X; Rhee Y; Condon KW; Bivi N; Allen MR; Dwyer D; Stolina M; Turner CH; Robling AG; Plotkin LI; Bellido T
    Bone; 2012 Jan; 50(1):209-17. PubMed ID: 22075208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mTORC1 activation in B cells confers impairment of marginal zone microarchitecture by exaggerating cathepsin activity.
    Meena NK; Pattanayak SP; Ben-Nun Y; Benhamron S; Kumar S; Merquiol E; Hövelmeyer N; Blum G; Tirosh B
    Immunology; 2018 Dec; 155(4):505-518. PubMed ID: 30144045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein.
    Gould NR; Williams KM; Joca HC; Torre OM; Lyons JS; Leser JM; Srikanth MP; Hughes M; Khairallah RJ; Feldman RA; Ward CW; Stains JP
    Elife; 2021 Mar; 10():. PubMed ID: 33779549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma.
    Delgado-Calle J; Anderson J; Cregor MD; Hiasa M; Chirgwin JM; Carlesso N; Yoneda T; Mohammad KS; Plotkin LI; Roodman GD; Bellido T
    Cancer Res; 2016 Mar; 76(5):1089-100. PubMed ID: 26833121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells.
    Papanicolaou SE; Phipps RJ; Fyhrie DP; Genetos DC
    Biorheology; 2009; 46(5):389-99. PubMed ID: 19940355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.